Business

Abattis annouces grant of options

Abattis annouces grant of options.

articleAbattis Bioceuticals CorpJuly 3, 20145/company/abattis-bioceuticals-corp/news/abattis-annouces-grant-of-options
Abattis annouces grant of options

About this update from Abattis Bioceuticals Corp

[{"type":"text","content":"\n \n Normal\n 0\n \n \n \n \n false\n false\n false\n \n EN-CA\n X-NONE\n X-NONE\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\nABATTIS ANNOUNCES GRANT\nOF OPTIONS\n\n \n\n \n\n \n\nVancouver, BC ? March 5,\n2014 - Abattis Bioceuticals Corp. (the ?Company? or ?Abattis?) (OTC PINK:\nATTBF) (CSE: ATT), wishes to announce\nthat it has granted incentive stock options to a consultant of the Company to\npurchase up to 121,000 common shares of the Company.  The options are exercisable on or before March\n5, 2019, at an exercise price of $0.64 per share.\n\n \n\n \n\nAbout Abattis\nBioceuticals Corp.\n\nAbattis is a specialty\nbiotechnology\ncompany with capabilities through its wholly owned\nsubsidiaries of cultivating, licensing and marketing\nproprietary\ningredients, bio-similar\ncompounds, patented equipment and consulting services to medicinal markets in North\nAmerica. The company is positioned to capitalize on the fast growing trend toward\nmarijuana legalization in the United States and for medicinal\nuse\nin Canada and\ninternational jurisdictions by\nsupplying and partnering with companies to employ its vertical cultivation systems, extraction equipment/technology, and strategic marketing support\nto licensed growers. The company also has an extensive pipeline of high-quality\nproducts and Intellectual Property\nfor the rapidly expanding botanical drug market. We follow\nstrict Standard Operating Protocols and adhere to the Law's of Canada and Foreign Jurisdictions.\nFor more information, visit the Company?s website at www.abattis.com.\n\n \n\nFor further information, contact the Company?s CEO, Michael Withrow at (778) 896-\n\n6536 or at [email protected].\n\n \n\nNEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER\nHAVE REVIEWED\nOR ACCEPT RESPONSIBILITY FOR\nTHE\nADEQUACY OR ACCURACY\nOF THIS RELEASE.\n\n \n\nFORWARD\nLOOKING INFORMATION\n\nThis press release contains\nforward-looking statements. The use of any of the words \"anticipate\", \"continue\", \"estimate\", \"expect\", \"may\", \"will\", \"project\", \"should\", \"believe\" and similar expressions are intended to identify forward-looking statements.  Although the\nCompany believes that the expectations and assumptions on which the forward-looking s...

More updates from Abattis Bioceuticals Corp